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Genomics in Latin America: Reaching the Frontiers
Pablo D. Rabinowicz1
Cold Spring Harbor Laboratory,Cold Spring Harbor, New York 11724, USA
When an undergraduate student in science from Latin
America is asked about career goals, the answer will
probably invoke dreams of using cutting-edge tech-
nologies to investigate the frontiers of science. For
these students, the realities of life in their countries
almost always reduce their options for achieving this
goal to only one: Emigrate to a developed country.
Although many of these countries produce numerous
international scientific papers relative to their small
research budget (Macilwain 1999a), their access to the
latest-generation technology is fairly limited. This is
particularly true in the field of genomics, in which the
need for automated, high-throughput equipment
raises the cost even more. However, when done wisely,
genomics research and development has proven to be
an affordable reality for developing countries. Choos-
ing the right model organism, organizing laboratory
networks instead of megalaboratories, and concentrat-
ing funding on one large project instead of splitting it
among many smaller ones are the methods by which
genomics is succeeding in Latin America. The need for
training scientists in disease-endemic countries led the
World Health Organization (WHO) to pledge almost
US $1 million to launch the Special Program for Re-
search and Training in Tropical Diseases (TDR), which
was the first broad genomic initiative involving Latin
American countries. The goal of TDR was to analyze
the genomes of three protozoan and two helminth
parasites that seriously affect developing countries:
Trypanosoma cruzi (Chagas disease), Trypanosmoa brucei
(African sleeping sickness), Leishmania major (leish-
maniasis), Burgia malayi (filariasis), and Schistosoma
mansoni (Schistosomiasis). The TDR projects were
meant to increase knowledge of the molecular biology
of these parasites and were especially oriented toward
the development of therapies, vaccines, and diagnos-
tics. North–South and South–South collaboration net-
works were organized so that expertise and technology
could be transferred and distributed throughout these
networks (Degrave et al. 1997; Johnston et al. 1999).
South American countries participate in three of the
five networks (T. cruzi [http://www.dbbm.fiocruz.br/
TcruziDB/index.html], leishmania [http://www.ebi.
ac.uk/parasites/leish.html], and schistosoma [http://
www.nhm.ac.uk/hosted_sites/schisto/index.html]),
together with many developed and developing coun-
tries around the world. Moreover, the T. cruzi network
was coordinated by a South American investigator
from the Institute of Technological Investigations at
the National University of General San Martı´n (IIB-
UNSAM), Argentina (Trypanosoma cruzi Consortium
1997), and a modest Schistosoma EST sequencing
project had begun earlier in Brazil (Pena 1996). After
five years, most of the specific aims of these collabora-
tive efforts were achieved. Now a number of resources
are available for each parasite, including large insert
libraries, EST and GSS sequence data, physical maps,
and databases. These resources are distributed among
the network participants and the community through
the Web. WHO’s funding for these initiatives was fairly
limited and was intended to be the primer for obtain-
ing additional funding from other agencies. Indeed,
parasite full-genome sequencing projects are now sup-
ported as a consequence of these early efforts. A re-
markable case is that of T. cruzi, a protozoan causing
the Chagas disease, which chronically or fatally affects
millions of people in South America. This parasite re-
ceived little attention from funding agencies before the
WHO decided to fund the genomics project. The in-
vestment proved to be successful, as sequencing and
mapping data became available from the collaborative
network (Ferrari et al. 1997; Verdu´n et al. 1998; Santos
et al. 1999; Agu¨ero et al. 2000; Porcel et al. 2000) and
the goal of attracting more funding agencies to extend
this research was achieved. Recently the National In-
stitute of Allergy and Infectious Diseases (NIAID) from
the National Institutes of Health (NIH) assigned a grant
to the Institute of Genome Research (TIGR), the Seattle
Biomedical Research Institute, and the University of
Uppsala to sequence the T. cruzi genome. This out-
come is fortunate for the T. cruzi research community
because the availability of extensive genomic data will
accelerate the development of therapeutic and diag-
nostic tools. Nevertheless, it highlights the usual gov-
ernmental policy in developing countries: not to fund
basic research unless an applicable product can be ob-
tained in the short term. When basic research is in the
area of genomics, it is even harder to convince the local
funding agencies to devote a substantial fraction of the
research and development budget to a single, but very
large, basic project that would yield just the raw mate-
rials for the preferred applied research.
Preferential support for applied research seems to
be the trend in the scientific funding policies of devel-
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oping countries. This makes sense, considering the
large international public efforts to generate and re-
lease genomic data to the public. Why would it be
worth devoting the small resources available in devel-
oping countries to joining in this effort when there are
so many other health and environmental problems in
the Third World to be taken care of? This “applied
versus basic” argument has long been present and was
raised again a few years after the beginning of the T.
cruzi genome project (Trypanosoma cruzi Consortium
1997). Paradigmatically, in spite of their efforts, groups
conforming the T. cruzi network could not obtain local
funding to complete the genome sequence. As a con-
sequence, the job ended up being done by labs in de-
veloped countries. For the supporters of the “applied”
policy, proof of the wisdom of their argument was that
even without cutting-edge technology and the full T.
cruzi genomic sequence data, several South American
countries have been recently declared free of Chagas
disease (http://www.who.int/tdr/diseases/chagas/
default.htm).
However, biological diversity is too large to assume
that all the valuable genetic information is already in
public or private databases, and the value of genomics
is not just in sequence information. It is also in the
development of technology to generate and analyze
genomic data, which in turn could lead to useful prod-
ucts. This was clearly seen by Brazilian scientists and
policymakers from the state of Sa˜o Paulo. In 1997, the
state science funding agency of Sa˜o Paulo (FAPESP)
committed more than US $11 million to completely
and accurately sequence the genome of Xylella fastidi-
osa, a phytopathogen that threatens orange cultiva-
tion, a major industry within this region (Bonalume´
1997). The funding received by this project alone rep-
resented a substantial proportion of the entire Brazil-
ian research budget. Nevertheless, this bacterium was
deemed agriculturally and economically important
enough to be worth the effort, although knowledge of
its complete genetic information would not give any
short-term applied benefit to citrus producers. Despite
this, the Sa˜o Paulo state citrus growers’ association
(Fundecitrus) also contributed US $500,000 to the
project (Macilwain 1999b), demonstrating their confi-
dence that this basic research would eventually yield
practical benefits for citrus production.
The significant amount of genomic information
expected to come from the X. fastidiosa genome project
has not been its only benefit. Thirty labs in the Sa˜o
Paulo region have been equipped and trained in state-
of-the-art technology instead of creating a center dedi-
cated to the project. These laboratories were organized
as a network known as the virtual institute ONSA
(http://watson.fapesp.br/genoma3.htm). The strategy
proved very successful in getting the job done at a high
standard of quality within the planned 2-yr timeframe,
as well as achieving the physical map (Frohme et al.
2000; Xylella fastidiosa Consortium 2000). The success
was far-reaching: As an immediate consequence,
FAPESP raised its bet and increased funding for ge-
nomic projects. Now, three more bacterial phyto-
pathogens are being sequenced in Sa˜o Paulo (a grape
strain of Xylella fastidiosa; Leifsonia xyli ssp. xyli, a sug-
arcane pathogen; and Xanthomonas citri, another citrus
pathogen), and a call has been issued for proposals to
sequence several more. Complex genomes, such as that
of sugar cane, are also being analyzed by EST ap-
proaches in which other Brazilian states are participat-
ing. Expansion of genomics efforts outside Sa˜o Paulo is
being promoted by the federal government through
the creation of more ONSA-like networks (Macilwain
and Bonalume Neto 2000). The Sa˜o Paulo initiative
also gives an example of the technological develop-
ment often derived from ongoing genomic projects.
After being preliminarily assayed in the S. mansoni
genome project in Brazil (Dias Neto et al. 1997), the
ORESTES technique (open reading frame ESTs) became
an optional approach for obtaining human EST se-
quences spanning the open reading frames (de Souza et
al. 2000; Dias Neto et al. 2000).
Thus, the effort invested by Brazil is paying off.
Having shown that Brazilian labs are up to date with
genomic technology, the Federal University of Pelotas
became a member of the International Rice Genome
Sequencing Project (IRGSP; Eckardt 2000). But perhaps
the most remarkable consequence of the Brazilian ex-
perience is the fact that funding for genomic projects
in Brazil is now also coming from abroad. The United
States Department of Agriculture (USDA) is financing
one-half of the US $500,000 that the sequencing of the
grape strain of X. fastidiosa will cost, and the United
States–based Ludwig Institute for Cancer Research is sup-
plying one-half of the US $10 million that ONSA will use
to produce up to one million ESTs from human tumors.
All of these achievements have been celebrated in
a range of media, from the covers of scientific journals
to the New York Times, as well as in local newspapers
and on television. In some cases, this might have of-
fered a false image of abundance and prosperity in Bra-
zilian science, which could compete with leading labs
worldwide to attract young Latin American scientists.
Several Brazilian scientists working either in Brazil or
the United States disagree with this image of general-
ized scientific prosperity in their country (Ho¨tzel 2000;
Prolla 2000). But the unquestionable merit of the Bra-
zilian endeavor is yielding invaluable fruits and will
hopefully catalyze improvements in the country’s sci-
entific system.
Following the same track as Brazil, Mexico has also
engaged in bacterial genomics. Two megaplasmids
from the nitrogen-fixing bacterium Rhizobium etli have
been sequenced, and the complete genome sequence is
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in the pipeline in the Center for Research in Nitrogen
Fixation (CIFN; http://itzamna.cifn.unam.mx) at the
National Autonomous University of Mexico (UNAM).
Funding for these projects comes from the National
Council for Research and Technology (CONACYT),
which has also recently made a significant gamble in
assigning a US $2 million grant to the Center for Ad-
vanced Research Studies (CINVESTAV) to carry on a
maize functional genomics project. This investment
represents 2% of the country’s current yearly research
and development budget, comparable to the propor-
tion of the United States National Science Foundation
(NSF) budget assigned to new plant genomics projects
in recent years. One goal of the maize functional ge-
nomics effort is to gather sequence information for ag-
riculturally important maize genes. In this way, they
can seek legal protection for genes particularly relevant
to local production. Another goal is to train human
resources in new technologies, now absent in the
country, that in turn will allow the Mexican scientific
community to participate in future postgenomic inter-
national projects.
Other countries, such as Argentina, are still dis-
cussing whether they should make real investments in
genomics. Meanwhile, some researchers in these coun-
tries are trying to keep up with genomic technology by
maintaining their participation in the international
networks or by generating new lower-scale projects,
such as the genomic analysis of the sunflower, which is
being carried out by several groups at the National In-
stitute of Agricultural Technology (INTA). These re-
searchers have begun sequencing several thousand
sunflower ESTs as well as constructing a BAC library
and mapping the genome using several approaches (N.
Paniego, M. Echaide, M. Muñoz, L. Fernández, S. To-
rales, P. Faccio, I. Fuksan, M. Carrera, R. Zandomeni,
E.Y. Suárez, and H.E. Hopp pers. comm.). Other re-
search groups at the same institute in collaboration
with the IIB-UNSAM carried out a medium-scale ge-
nomic sequencing project aiming at gene discovery in
the cattle pathogen Brucella abortus (Sa´nchez et al.
2001). The IIB-UNSAM is now using internal money to
pursue the genomic sequencing of Campylobacter fetus,
another cattle pathogen.
Interestingly enough, the Max Planck Institute in
Goettingen, Germany, has decided to support the cre-
ation of a center for genomics at the National Univer-
sity of La Plata. This initiative was launched together
with the Association of Universities of the Montevideo
Group (AUGM), which includes several South Ameri-
can countries. The joint initiative will represent an in-
vestment of several million dollars. By the end of 2001,
when the center is expected to open, several research
groups will be established and ∼25 people will be hired.
Perhaps this will mark a change in Argentinean politics
regarding investing in genomics.
There are certainly many young Latin American
scientists willing to take open positions to work
on genomics. This was evident by the 110 applica-
tions to participate in a recent practical course on ge-
nomic sequencing and annotation (http://www.
hhmi.org/grants/international/educate/past.htm;
http://genoma.dna.uba.ar:8080) held at the Institute
for Research in Genetic Engineering and Molecular Bi-
ology (INGEBI), Buenos Aires, and organized by the US
National Academies with funding from the Howard
Hughes Medical Institute (HHMI) and the Argentin-
ean–Brazilian Center for Biotechnology (CABBIO).
Nineteen students from eight Latin American coun-
tries had a chance to experience high-throughput ge-
nomics and, perhaps more important, to interact with
experts from leading institutions and companies like
the Genome Sequencing Center at Washington Uni-
versity, Cold Spring Harbor Laboratory, the Microarray
Database at the School of Medicine from Stanford Uni-
versity, the Ludwig Institute for Cancer Research, (São
Paulo, Brazil) and Cereon Genomics (Cambridge, MA).
Among the students, there were members of some
Latin American laboratories that are beginning to get
involved in genomic sequencing projects. Genomics-
related events such as this course, which are thus far
fairly unusual, constitute a way to train people and
establish collaborations between Latin American labo-
ratories and strong genomics institutions in neighbor
or central countries.
Clearly, the importance of being part of the new
era in biology is becoming more and more evident in
Latin America. Successful examples have proven that it
is possible to do genomics and that these efforts gen-
erate resources and expertise, promote technology
transfer, allow participation in international initia-
tives, and attract funding. By no means will they im-
mediately create a scientific paradise, but these early
efforts are definitely helping Latin American countries
to increase their scientific impact at the international
level and to stop their brain drain. The generalization
of these ideas might very well be the way for these
countries to recover their scientific future: those rising
students who emigrated in search of scientific fron-
tiers.
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